SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Sesplankis Jeffrey M

(Last) (First) (Middle)
C/O DELPHI TECHNOLOGIES PLC
1 ANGEL COURT, 10TH FLOOR

(Street)
LONDON X0 EC2R 7HJ

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Delphi Technologies PLC [ DLPH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/28/2019
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 02/28/2019 X(1) 50 A $0.00 2,018 D
Ordinary Shares 02/28/2019 X(2) 1,328 A $0.00 3,346 D
Ordinary Shares 02/28/2019 X(2) 498 A $0.00 3,844 D
Ordinary Shares 02/28/2019 A(3) 437 A $0.00 4,281 D
Ordinary Shares 02/28/2019 F(4) 642 D $0.00 3,639(5) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Dividend Equivalent Rights (6) 02/28/2019 X 50 (6) (6) Ordinary Shares 50 $0.00 59.56 D
Restricted Share Units (7) 02/28/2019 X 1,328 (7) (7) Ordinary Shares 1,328 $0.00 4,151 D
Restricted Share Units (8) 02/28/2019 X 498 (8) (8) Ordinary Shares 498 $0.00 3,653 D
Restricted Share Units (9) 02/28/2019 A 5,432 (9) (9) Ordinary Shares 5,432 $0.00 5,432 D
Restricted Share Units (10) 02/28/2019 A 4,938 (10) (10) Ordinary Shares 4,938 $0.00 10,370 D
Explanation of Responses:
1. Represents the acquisition of ordinary shares upon the disposition of dividend equivalent rights reported in Table 2.
2. Represents the acquisition of ordinary shares upon the disposition of restricted share units reported in Table 2.
3. Ordinary shares received upon settlement of performance based awards granted pursuant to an approved employee incentive plan the value and issuance of which was conditioned on the Issuer achieving certain operating and financial performance targets over the 2016 through 2018 fiscal year period.
4. Represents ordinary shares being withheld to pay tax liability incident to the vesting of time-based restricted stock units and settlement of dividend equivalent rights previously granted pursuant to an approved employee incentive plan.
5. Includes Ordinary Shares plus an additional 245 of restricted stock units previously granted pursuant to an approved employee incentive plan, which vest at various points with the passage of time and which earn dividend equivalents until fully vested.
6. Reflects settlement of dividend equivalent rights in connection with the vesting of restricted share units. The rights accrued when and as dividends were paid on the Issuer's ordinary shares and vested proportionately with the restricted share units to which they related. Each dividend equivalent right is the economic equivalent of one ordinary share.
7. Reflects settlement of a portion of restricted share units awarded to the reporting person as a one-time special grant pursuant to Rule 16b-3, each of which represents the right to receive one ordinary share of the Issuer (but which may be settled in cash in certain circumstances). The remaining award vests in two equal installments on each of February 28, 2020 and February 28, 2021.
8. Reflects settlement of a portion of restricted share units awarded to the reporting person as an annual grant pursuant to Rule 16b-3, each of which represents the right to receive one ordinary share of the Issuer (but which may be settled in cash in certain circumstances). The remaining award vests in two equal installments on each of February 28, 2020 and February 28, 2021.
9. Reflects the annual grant of restricted share units awarded to the reporting person pursuant to Rule 16b-3, each of which represents the right to receive one ordinary share of the Issuer (but which may be settled in cash in certain circumstances). The award vests in three equal installments on each of February 28, 2020, February 28, 2021 and February 28, 2022.
10. Reflects a one-time special grant of restricted share units awarded to the reporting person pursuant to Rule 16b-3, each of which represents the right to receive one ordinary share of the Issuer (but which may be settled in cash in certain circumstances). The award vests in three equal installments on each of February 28, 2020, February 28, 2021 and February 28, 2022.
Remarks:
/s/ James D. Harrington, Attorney-in-Fact for Jeffrey M. Sesplankis 03/04/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.